Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.

Saved in:
Bibliographic Details
Title: Longitudinal risk of serious infections in patients with inflammatory arthritis on immunomodulating therapy compared to controls.
Authors: Christensen IE; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Lillegraven S; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Sexton J; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway., Kvien TK; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Uhlig T; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Provan SA; Center for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.; Public Health Section, Inland Norway University of Applied Sciences, Elverum, Norway.
Source: Rheumatology advances in practice [Rheumatol Adv Pract] 2025 Feb 12; Vol. 9 (1), pp. rkaf017. Date of Electronic Publication: 2025 Feb 12 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101736676 Publication Model: eCollection Cited Medium: Internet ISSN: 2514-1775 (Electronic) Linking ISSN: 25141775 NLM ISO Abbreviation: Rheumatol Adv Pract Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2514-1775
DOI:10.1093/rap/rkaf017